Revlimid–Risk after failed SCT

I’ve just been doing a bit more research into the situation that I am in and came across this article on the MyelomaBeacon site.

Revlimid Maintenance Therapy After Donor Stem Cell Transplantation Is Not Recommended For Multiple Myeloma Patients

Although there are slight differences, I think it shows how risky this process is going to be for me.

I’m currently managing OK with the Acute GVHD that I have have, but come the new year when I start on Revlimid the risk of getting Chronic GVHD looks more likely, so I’m sure they will be monitoring me even more closely.

My Life with Myeloma Sean Tiernan